Advocacy Strategy 2018
MS Ireland has published our Advocacy Strategy for 2018, which details the actions we will be taking this year to try and address each of our advocacy priority areas. You can download the strategy here
News
Ocrelizumab Receives Licence in EU
Roche’s ocrelizumab receives licence in the EU for relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS)
A Year of Hellos and Goodbyes for MS & Me
With the turn of the New Year MS & Me is expanding and diversifying. In this post, we also say ‘goodbye’ to a number of friends
Multiple Sclerosis: The Facts
More than 10,000 people are living with Multiple Sclerosis in Ireland. Multiple Sclerosis (MS), meaning ‘many scars’, is the most common disabling neurological disease affecting young adults in Ireland. MS impacts the motor, sensory and cognitive functioning of the body and is usually diagnosed between 20 and 40 years of age.
All-Island Multiple Sclerosis Research Study Launched
Irish life sciences company, Genomics Medicine Ireland (GMI) have announced an important scientific research study aimed at unlocking the mystery of the genetic and lifestyle factors that contribute to MS. Volunteers with MS currently being treated at St. Vincent’s University Hospital, Tallaght Hospital, Cork University Hospital or Altnagelvin Hospital in Derry are invited to participate in the study which aims to identify these factors in order to find better treatments, diagnoses and, ultimately, a cure for MS. GMI also hopes to rollout additional study sites around the country in future.
HSE Service Plan 2018
Yesterday the HSE published their Service Plan for 2018. The plan is available here.
How About The Best Christmas Ever!
This week from the MS & Me blog archive Emma Rogan shares her thoughts on minding your energy levels, minding your mind and making it the Best Christmas, EVER!